Presentation is loading. Please wait.

Presentation is loading. Please wait.

A Stepping Stone Toward Personalized Oncology: Genomic Analysis of Circulating Tumor Cells to Guide Management of Metastatic Castration-resistant Prostate.

Similar presentations


Presentation on theme: "A Stepping Stone Toward Personalized Oncology: Genomic Analysis of Circulating Tumor Cells to Guide Management of Metastatic Castration-resistant Prostate."— Presentation transcript:

1 A Stepping Stone Toward Personalized Oncology: Genomic Analysis of Circulating Tumor Cells to Guide Management of Metastatic Castration-resistant Prostate Cancer  Archana Anantharaman, Terence W. Friedlander  European Urology  Volume 68, Issue 6, Pages (December 2015) DOI: /j.eururo Copyright © 2015 European Association of Urology Terms and Conditions

2 Fig. 1 Representation of splicing of androgen receptor (AR) to full length, wild-type AR versus truncated, constitutively active splice variant AR-V7. Absence of LBD in AR-V7 prevents activity of available AR targeted agents. AA=antiandrogen therapy (eg, bicalutamide, nilutamide, flutamide, enzalutamide); AR=androgen receptor; DBD=DNA binding domain; DHT=dihydrotestosterone; LBD=ligand binding domain; NTD=N-terminal domain. European Urology  , DOI: ( /j.eururo ) Copyright © 2015 European Association of Urology Terms and Conditions


Download ppt "A Stepping Stone Toward Personalized Oncology: Genomic Analysis of Circulating Tumor Cells to Guide Management of Metastatic Castration-resistant Prostate."

Similar presentations


Ads by Google